Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein
KEYWORDS: people, vte, prophylaxis, risk, vte prophylaxis, surgery, lmwh, use, risk vte, pharmacological, consider, bleeding, undergoing, people undergoing, person

recommendations on apixaban, aspirin, dabigatran etexilate, fondaparinux sodium, low-molecular-weight heparin (LMWH) and rivaroxaban in this guideline. [2018] In March 2018, the use of these drugs in young people under 18 was off label. See NICE's information on prescribing medicines. All surgery 1.3.13 Advise people to consider stopping oestrogen-containing oral contraceptives or hormone replacement therapy 4 weeks before elective surgery. If stopped, provide advice on alternative contraceptive methods. [2010] Nursing care: early mobilisation and hydration 1.3.14 Encourage people to mobilise as soon as possible. [2010] 1.3.15 Do not allow people to become dehydrated unless clinically indicated. [2010] People using antiplatelet agents 1.3.16 Consider VTE prophylaxis for people who are having antiplatelet agents for other conditions and whose risk of VTE outweighs their risk of bleeding. Take into account the risk of bleeding and of comorbidities such as arterial thrombosis. • If the risk of VTE outweighs the risk of bleeding, consider pharmacological VTE prophylaxis based on their condition or procedure. • If the risk of bleeding outweighs the risk of VTE, consider mechanical VTE prophylaxis. [2018] People using anticoagulation therapy 1.3.17 Consider VTE prophylaxis for people at increased risk of VTE who are interrupting anticoagulant therapy. [2018] 1.4 Interventions for people
